Delivery Order SPE2DB22D1017-SPE2DB25FG9FX
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $2,564.77 delivery order by the Defense Logistics Agency on September 8, 2025, for the supply of Ambien CR 6.25 mg tablets (100 count). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 9, 2025. The contract is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,687.77 by the Defense Logistics Agency (DLA) on September 15, 2025, with an ultimate completion date of September 16, 2025. The contract is for the supply of Ambien CR 6.25 mg tablets in quantities of 100, to be delivered to the contractor's location in Conshohocken, Pennsylvania. This is a firm fixed-price delivery order with no set-aside designation, awarded through competitive procurement on a non-set-aside basis. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units, with a contract ceiling value of $3,247.94. This is a firm fixed-price delivery order with an ultimate completion date of August 29, 2025, and represents a competitively awarded, non-set-aside contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Ambien CR 6.25 mg tablets (100-count) valued at $2,354.12. This competitive award, issued with firm fixed pricing, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order will be fulfilled at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,890.69 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitive award, issued under firm fixed pricing with no set-aside designation, represents a continuation of the company's pharmaceutical supply services to federal medical procurement needs. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a $3,439.09 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100. The contract, which is not subject to any set-aside designation, was competitively awarded and carries an ultimate completion date of August 19, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as both the place of performance and the location from which this major...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,331.08 for Ambien CR 6.25 mg tablets (100-count units) on September 23, 2025, with completion scheduled for September 24, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The pharmaceutical distributor will perform the delivery order from its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Ambien CR 6.25 mg tablets (100-count units) with a contract ceiling value of $2,237.57. This is a firm fixed price delivery order with no set-aside designation, indicating the award was competitively procured. The order is scheduled for completion by September 22, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) on September 23, 2025, valued at $4,288.38 with an ultimate completion date of September 24, 2025. The contract is for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units. This award represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units, with a contract ceiling value of $1,370.38. This firm fixed-price delivery order, set to be completed by August 18, 2025, is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement through December 2026 that provides...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG9FXDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 8, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units, valued at $1,804.72. This is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's ability to meet federal procurement requirements through open competition. This delivery order is executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 blanket agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for the military health system. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a broad portfolio of medications and medical supplies to support defense and veteran healthcare systems worldwide. This particular delivery order represents one of numerous small-to-moderate value transactions executed under the prime IDC to fulfill ongoing pharmaceutical supply needs across the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 8/8/25 |